Evelo Biosciences (EVLO) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free EVLO Stock Alerts $0.04 -0.01 (-19.76%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 2:16 AM | americanbankingnews.comTraders Buy High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)February 22, 2024 | benzinga.comEvelo Biosciences Stock (OTC:EVLO), Short Interest ReportNovember 24, 2023 | msn.comEvelo Biosciences, a microbiome company launched by Flagship, shuts downNovember 22, 2023 | bizjournals.comFlagship-backed startup Evelo, behind failed eczema drug, to dissolveNovember 14, 2023 | finance.yahoo.comFMR LLC Reduces Stake in Evelo Biosciences IncNovember 10, 2023 | morningstar.comEvelo Biosciences Inc EVLONovember 2, 2023 | finance.yahoo.comQ3 2023 Horizon Technology Finance Corp Earnings CallNovember 2, 2023 | finance.yahoo.comHorizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call TranscriptNovember 1, 2023 | msn.comEvelo Biosciences (EVLO) Price Target Increased by 53.85% to 10.20October 19, 2023 | msn.comTD Cowen Downgrades Evelo Biosciences (EVLO)October 18, 2023 | finance.yahoo.comEvelo (EVLO) Drops 59% on Flunking Psoriasis Drug StudyOctober 17, 2023 | marketwatch.comEvelo Biosciences Shares Down 58% After Unfavorable EDP2939 ResultsOctober 17, 2023 | markets.businessinsider.comHold Rating on Evelo Biosciences amid Unfavorable Outcomes and Strategic Changes: An Analyst Recommendation ReportOctober 17, 2023 | seekingalpha.comEvelo drops as mid-stage trial for psoriasis drug failsOctober 17, 2023 | proactiveinvestors.comEvelo Biosciences shares tank 46% after trial failureOctober 17, 2023 | markets.businessinsider.comEvelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic AlternativesOctober 17, 2023 | msn.comWhy Is Psoriasis Company Evelo Biosciences Stock Plunging Today?October 17, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 09:10 AM with a stated reason of "LULD pause."October 17, 2023 | marketwatch.comEvelo Biosciences Reviewing Alternatives After Study Didn't Meet EndpointOctober 17, 2023 | marketwatch.comEvelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goalOctober 17, 2023 | finance.yahoo.comEvelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate PsoriasisOctober 17, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 06:10 AM with a stated reason of "News pending."August 18, 2023 | seekingalpha.comEvelo Biosciences down 39% as 13M share offering beginsAugust 18, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 10:08 AM with a stated reason of "LULD pause."August 18, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 09:08 AM with a stated reason of "LULD pause."August 14, 2023 | finanznachrichten.deEvelo Biosciences, Inc.: Evelo Biosciences Announces Second Quarter Financial Results and Recent Business HighlightsAugust 14, 2023 | finance.yahoo.comEvelo Biosciences Announces Second Quarter Financial Results and Recent Business HighlightsAugust 11, 2023 | finance.yahoo.comFMR LLC Acquires Significant Stake in Evelo Biosciences IncJuly 27, 2023 | msn.comMorgan Stanley Maintains Evelo Biosciences (EVLO) Equal-Weight RecommendationJuly 21, 2023 | benzinga.comWhy Are velo Biosciences Stock Is Trading Higher Today?July 21, 2023 | benzinga.comWhy Are Evelo Biosciences Stock Is Trading Higher Today?July 21, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 09:07 AM with a stated reason of "LULD pause."July 21, 2023 | theglobeandmail.comInstrument Name Evelo Biosciences Inc Instrument Symbol (EVLO-Q)July 18, 2023 | marketbeat.comTrading was temporarily halted for "EVLO" at 11:05 AM with a stated reason of "LULD pause."July 12, 2023 | finance.yahoo.comEvelo Biosciences Closes $25.5 Million Private PlacementJuly 11, 2023 | benzinga.comEvelo Biosciences shares are trading higher after the company announced a $25.5 million private placement.July 10, 2023 | marketwatch.comEvelo Biosciences Shares Rise 20% After Private Offering PricesJuly 10, 2023 | msn.comEvelo Biosciences Plans $25.5M Private Placement To Fund Psoriasis Trial, Pay Down DebtJuly 10, 2023 | finance.yahoo.comEvelo Biosciences Announces $25.5 Million Private PlacementJune 30, 2023 | finanznachrichten.deEvelo Biosciences, Inc.: Evelo Biosciences Announces Reverse Stock Split EffectiveJune 29, 2023 | msn.comWhy Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 29, 2023 | finance.yahoo.comEvelo Biosciences Announces Reverse Stock Split EffectiveJune 22, 2023 | finance.yahoo.comEVLO - Evelo Biosciences, Inc.June 20, 2023 | investorplace.comWhy Is Evelo Biosciences (EVLO) Stock Up 51% Today?June 15, 2023 | benzinga.comEvelo Biosciences Granted U.S. Patent #11672834 For "PREBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF FOR MODULATION OF THE MICROBIOME"May 17, 2023 | finance.yahoo.comWhat Makes Evelo Biosciences, Inc. (EVLO) a New Buy StockMay 10, 2023 | finance.yahoo.comEvelo Biosciences Insiders Added US$575k Of Stock To Their HoldingsMay 10, 2023 | finance.yahoo.comEvelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \April 27, 2023 | markets.businessinsider.comEvelo Biosciences (EVLO) Gets a Hold from Morgan StanleyApril 27, 2023 | investorplace.comWhy Is Evelo Biosciences (EVLO) Stock Up 78% Today? Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. EVLO Media Mentions By Week EVLO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVLO News Sentiment▼0.320.42▲Average Medical News Sentiment EVLO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVLO Articles This Week▼20▲EVLO Articles Average Week Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EVFM News SBFM News SPRC News HSTO News LSDI News BLPH News CMRA News GRI News ADTX News NBSE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVLO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
